Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.

Source:http://linkedlifedata.com/resource/pubmed/id/21709185

J. Clin. Oncol. 2011 Aug 1 29 22 3037-43

Download in:

View as

General Info

PMID
21709185